Intellectual Property
Our industry continues to be a hotbed of patent innovation, with Caris leading the way. Activity is driven by the increasing volume and complexity of genomic information, necessitating faster and more accurate analysis for research, clinical diagnostics, and personalized medicine, and the growing importance of technologies.
- US 8,831,890
- US 8,914,239
- US 8,880,350
- US 9,383,365
- US 9,372,193
- US 9,053,224
- US 9,092,392
- US 9,064,045
- US 9,058,418
- US 9,292,660
- US 9,389,234
- US 11,315,673
Discover
More
Our commitment to advancing cancer care and molecular research spans more than a decade. We explore ways to improve patient care, enhance the healthcare delivery system, and transform precision medicine into reality.
We remain focused on the most important part of our work – the patient. Hear from those who courageously share their cancer journey including Caris molecular profiling, offering valuable insights and perspectives that go beyond the statistics and outcomes.